Association Between Atherosclerosis and Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes Mellitus

References

• Heng LZ, Comyn O, Peto T, et al. Diabetic retinopathy: pathogenesis, clinical grading, management and future developments. Diabet Med. 2013;30(6):640–650. doi:10.1111/dme.12089
   PubMed Web of Science ®Google Scholar
• Leasher JL, Bourne RR, Flaxma SR, et al. Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 1990–2010. Diabetes Care. 2016;39(9):1643–1649. doi:10.2337/dc15-2171
   PubMed Web of Science ®Google Scholar
• Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–564. doi:10.2337/dc11-1909
   PubMed Web of Science ®Google Scholar
• Song P, Yu J, Chan KY, et al. Prevalence, risk factors and burden of diabetic retinopathy in China: a systematic review and meta-analysis. J Glob Health. 2018;8(1):010803. doi:10.7189/jogh.08.010803
   PubMed Web of Science ®Google Scholar
• Cheung N, Wong TY. Diabetic retinopathy and systemic vascular complications. Prog Retin Eye Res. 2008;27(2):161–176. doi:10.1016/j.preteyeres.2007.12.001
   PubMed Web of Science ®Google Scholar
• Juutilainen A, Lehto S, Ronnemaa T, et al. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women. Diabetes Care. 2007;30(2):292–299. doi:10.2337/dc06-1747
   PubMed Web of Science ®Google Scholar
• Kramer CK, Rodrigues TC, Canani LH, et al. Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies. Diabetes Care. 2011;34(5):1238–1244. doi:10.2337/dc11-0079
   PubMed Web of Science ®Google Scholar
• Lusis AJ. Atherosclerosis. Nature. 2000;407(6801):233–241. doi:10.1038/35025203
   PubMed Web of Science ®Google Scholar
• DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The claude bernard lecture 2009. Diabetologia. 2010;53(7):1270–1287. doi:10.1007/s00125-010-1684-1
   PubMed Web of Science ®Google Scholar
• Li MF, Zhao CC, Li TT, et al. The coexistence of carotid and lower extremity atherosclerosis further increases cardio-cerebrovascular risk in type 2 diabetes. Cardiovasc Diabetol. 2016;15(1):43. doi:10.1186/s12933-016-0360-2
   PubMedGoogle Scholar
• Blankenhorn DH, Kramsch DM. Reversal of atherosis and sclerosis. The two components of atherosclerosis. Circulation. 1989;79(1):1–7. doi:10.1161/01.CIR.79.1.1
   PubMed Web of Science ®Google Scholar
• Chen SC, Hsiao PJ, Huang JC, et al. Abnormally low or high ankle-brachial index is associated with proliferative diabetic retinopathy in type 2 diabetic mellitus patients. PLoS One. 2015;10(7):e0134718. doi:10.1371/journal.pone.0134718
   PubMedGoogle Scholar
• Ogawa O, Hayashi C, Nakaniwa T, et al. Arterial stiffness is associated with diabetic retinopathy in type 2 diabetes. Diabetes Res Clin Pract. 2005;68(2):162–166. doi:10.1016/j.diabres.2004.09.008
   PubMedGoogle Scholar
• Liu Y, Teng X, Zhang W, et al. Association between diabetic retinopathy and subclinical atherosclerosis in China: results from a community-based study. Diab Vasc Dis Res. 2015;12(5):366–372. doi:10.1177/1479164115591744
   PubMedGoogle Scholar
• Yun YW, Shin MH, Lee YH, et al. Arterial stiffness is associated with diabetic retinopathy in Korean type 2 diabetic patients. J Prev Med Public Health. 2011;44(6):260–266. doi:10.3961/jpmph.2011.44.6.260
   PubMedGoogle Scholar
• Miyamoto M, Kotani K, Okada K, et al. The correlation of common carotid arterial diameter with atherosclerosis and diabetic retinopathy in patients with type 2 diabetes mellitus. Acta Diabetol. 2012;49(1):63–68. doi:10.1007/s00592-011-0287-8
   PubMedGoogle Scholar
• Van Hecke MV, Dekker JM, Nijpels G, et al. Are retinal microvascular abnormalities associated with large artery endothelial dysfunction and intima-media thickness? The hoorn study. Clin Sci (Lond). 2006;110(5):597–604. doi:10.1042/CS20050270
   PubMed Web of Science ®Google Scholar
• Palombo C, Kozakova M. Arterial stiffness, atherosclerosis and cardiovascular risk: pathophysiologic mechanisms and emerging clinical indications. Vascul Pharmacol. 2016;77:1–7. doi:10.1016/j.vph.2015.11.083
   PubMed Web of Science ®Google Scholar
• Cardoso CR, Ferreira MT, Leite NC, et al. Microvascular degenerative complications are associated with increased aortic stiffness in type 2 diabetic patients. Atherosclerosis. 2009;205(2):472–476. doi:10.1016/j.atherosclerosis.2008.12.027
   PubMedGoogle Scholar
• Yamashina A, Tomiyama H, Takeda K, et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res. 2002;25(3):359–364. doi:10.1291/hypres.25.359
   PubMed Web of Science ®Google Scholar
• Yambe T, Yoshizawa M, Saijo Y, et al. Brachio-ankle pulse wave velocity and cardio-ankle vascular index (CAVI). Biomed Pharmacother. 2004;58(Suppl 1):S95–S98. doi:10.1016/S0753-3322(04)80015-5
   PubMedGoogle Scholar
• Nakamura K, Tomaru T, Yamamura S, et al. Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis. Circ J. 2008;72(4):598–604. doi:10.1253/circj.72.598
   PubMed Web of Science ®Google Scholar
• Takaki A, Ogawa H, Wakeyama T, et al. Cardio-ankle vascular index is superior to brachial-ankle pulse wave velocity as an index of arterial stiffness. Hypertens Res. 2008;31(7):1347–1355. doi:10.1291/hypres.31.1347
   PubMedGoogle Scholar
• Shirai K, Utino J, Otsuka K, et al. A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb. 2006;13(2):101–107. doi:10.5551/jat.13.101
   PubMed Web of Science ®Google Scholar
• Ibata J, Sasaki H, Kakimoto T, et al. Cardio-ankle vascular index measures arterial wall stiffness independent of blood pressure. Diabetes Res Clin Pract. 2008;80(2):265–270. doi:10.1016/j.diabres.2007.12.016
   PubMedGoogle Scholar
• Satoh-Asahara N, Kotani K, Yamakage H, et al. Cardio-ankle vascular index predicts for the incidence of cardiovascular events in obese patients: a multicenter prospective cohort study (Japan Obesity and Metabolic Syndrome Study: JOMS). Atherosclerosis. 2015;242(2):461–468. doi:10.1016/j.atherosclerosis.2015.08.003
   PubMed Web of Science ®Google Scholar
• Hitsumoto T. Clinical usefulness of the cardio-ankle vascular index as a predictor of primary cardiovascular events in patients with chronic kidney disease. J Clin Med Res. 2018;10(12):883–890. doi:10.14740/jocmr3631
   PubMedGoogle Scholar
• Shirai K, Utino J, Saiki A, et al. Evaluation of blood pressure control using a new arterial stiffness parameter, cardio-ankle vascular index (CAVI). Curr Hypertens Rev. 2013;9(1):66–75. doi:10.2174/1573402111309010010
   PubMedGoogle Scholar
• Wilkinson CP, Ferris FL, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677–1682. doi:10.1016/S0161-6420(03)00475-5
   PubMed Web of Science ®Google Scholar
• Touboul PJ, Hennerici MG, Meairs S, et al. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European stroke conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis. 2012;34(4):290–296. doi:10.1159/000343145
   PubMed Web of Science ®Google Scholar
• CAVI. Fukuda-Denshi Company L, Tokyo, Japan. Available from: http://www.fukuda.co.jp/english/products/special_features/vasera/cavi.html. Accessed July 27, 2019.
   Google Scholar
• Chinese Diabetes Society. Chinese Society of Infectious Disease, Chinese Society or tissue repair and regeneration. Chinese guideline on prevention and management of diabetic foot (2019 edition). Chin J Diabetes Mellitus. 2019;11:92–108.
   Google Scholar
• Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937–2944. doi:10.1681/ASN.2006040368
   PubMed Web of Science ®Google Scholar
• Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: improving Global Outcomes (KDIGO). Kidney Int. 2005;67(6):2089–2100. doi:10.1111/j.1523-1755.2005.00365.x
   PubMed Web of Science ®Google Scholar
• Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia. 2001;44(2):156–163. doi:10.1007/s001250051594
   PubMed Web of Science ®Google Scholar
• Chew EY, Davis MD, Danis RP, et al. The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study. Ophthalmology. 2014;121(12):2443–2451. doi:10.1016/j.ophtha.2014.07.019
   PubMed Web of Science ®Google Scholar
• Lee MY, Hsiao PJ, Huang JC, et al. Associations between triglyceride/high-density lipoprotein cholesterol ratio and micro- and macroangiopathies in type 2 diabetes mellitus. Endocr Pract. 2018;24(7):615–621. doi:10.4158/EP-2017-0254
   PubMedGoogle Scholar
• Di Angelantonio E, Sarwar N, et al.; Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302:1993–2000.
   PubMed Web of Science ®Google Scholar
• Barter P, Gotto AM, LaRosa JC, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med. 2007;357(13):1301–1310. doi:10.1056/NEJMoa064278
   PubMed Web of Science ®Google Scholar
• Barter P, Genest J. HDL cholesterol and ASCVD risk stratification: a debate. Atherosclerosis. 2019;283:7–12. doi:10.1016/j.atherosclerosis.2019.01.001
   PubMed Web of Science ®Google Scholar
• Holmes MV, Asselbergs FW, Palmer TM. Mendelian randomization of blood lipids for coronary heart disease. Eur Heart J. 2015;36(9):539–550. doi:10.1093/eurheartj/eht571
   PubMed Web of Science ®Google Scholar
• Alonso N, Traveset A, Rubinat E, et al. Type 2 diabetes-associated carotid plaque burden is increased in patients with retinopathy compared to those without retinopathy. Cardiovasc Diabetol. 2015;14(1):33. doi:10.1186/s12933-015-0196-1
   PubMedGoogle Scholar
• Saif A, Karawya S, Abdedhamid A. Retinopathy is a strong determinant of atherosclerosis in type 2 diabetes: correlation with carotid intima media thickness. Endocr Pract. 2015;21(3):226–230. doi:10.4158/EP14390.OR
   PubMed Web of Science ®Google Scholar
• Ogawa O, Hiraoka K, Watanabe T, et al. Diabetic retinopathy is associated with pulse wave velocity, not with the augmentation index of pulse waveform. Cardiovasc Diabetol. 2008;7(1):11. doi:10.1186/1475-2840-7-11
   PubMedGoogle Scholar
• Shirai K. Analysis of vascular function using the cardio-ankle vascular index (CAVI). Hypertens Res. 2011;34(6):684–685. doi:10.1038/hr.2011.40
   PubMed Web of Science ®Google Scholar
• Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes. 2008;26(2):77–82. doi:10.2337/diaclin.26.2.77
   Google Scholar
• Yokoyama H, Aoki T, Imahori M, et al. Subclinical atherosclerosis is increased in type 2 diabetic patients with microalbuminuria evaluated by intima-media thickness and pulse wave velocity. Kidney Int. 2004;66(1):448–454. doi:10.1111/j.1523-1755.2004.00752.x
   PubMed Web of Science ®Google Scholar
• Brownrigg JR, Hughes CO, Burleigh D, et al. Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study. Lancet Diabetes Endocrinol. 2016;4(7):588–597. doi:10.1016/S2213-8587(16)30057-2
   PubMed Web of Science ®Google Scholar
• Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615–1625. doi:10.2337/diabetes.54.6.1615
   PubMed Web of Science ®Google Scholar